FDA — authorised 14 September 1963
- Application: NDA013601
- Marketing authorisation holder: APOTHECON
- Local brand name: MUCOMYST
- Indication: SOLUTION — INHALATION, ORAL
- Status: approved
🇺🇸 n-acetylcystine + albuterol in United States
FDA authorised n-acetylcystine + albuterol on 14 September 1963
Marketing authorisation
Other Respiratory approved in United States
Frequently asked questions
Is n-acetylcystine + albuterol approved in United States?
Yes. FDA authorised it on 14 September 1963.
Who is the marketing authorisation holder for n-acetylcystine + albuterol in United States?
APOTHECON holds the US marketing authorisation.